追标
追标Logo
追标
顺式-4-[(4-氯苯基)磺酰基]-4-(2,5-二氟苯基)环己烷丙酸 CAS: 471905-41-6
cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid
生物化工
2D 矢量分子结构式
多维分析谱图直达 已收录 1 种
基本理化与登记标识
CAS 登记号 471905-41-6
分子式 C21H21ClF2O4S
分子量 (MW) 443.0 g/mol
EINECS 编号 --
中文别名 顺式-4-[(4-氯苯基)磺酰基]-4-(2,5-二氟苯基)环己烷丙酸, 一种适度有效的Γ-SECRETASE(Γ-分泌酶)抑制剂;顺式-4-[(4-氯苯基)磺酰基]-4-(2,5-二氟苯基)环己烷丙酸
规范 SMILES C1CC(CCC1CCC(=O)O)(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl
InChIKey XCGJIFAKUZNNOR-UHFFFAOYSA-N
主要用途与行业
生物活性 MK-0752是一种适度有效的γ-secretase(γ-分泌酶)抑制剂,降低Aβ40产量,IC50为5 nM。Phase 1/2... 查看详细工业用途与工艺规范
主要用途、行业应用与生产工艺 涵盖工业生产、分析检测、配方原料及安全限量
主要工业与科研应用

生物活性 MK-0752是一种适度有效的γ-secretase(γ-分泌酶)抑制剂,降低Aβ40产量,IC50为5 nM。Phase 1/2。体外研究 MK-0752 is identified as a moderately potent γ-secretase inhibitor, which reduces Aβ40 in a dose-dependent manner with an IC50 of 5 nM in human SH-SY5Y cells. In vitro, MK-0752 blocks Notch-intracellular domain (ICD) cleavage and its subsequent nuclear translocation. 体内研究 MK-0752 (240 mg/kg) reduces the generation of newly produced Aβ with 90% decrease of AUV in the brain of rhesus monkeys. In addition, MK-0752 treatment increases levels of Aβ 1-14, Aβ 1-15, and Aβ 1-16 , while decreases levels of Aβ 1-17. In guinea-pigs, oral administration of MK-0752 (10 mg/kg -30 mg/kg) results in the dose-dependent reduction of Aβ40 in plasma, brain and cerebrospinal fluid (CSF) with IC50 of 440 nM in brain. 特征 MK-0752 is a moderately potent γ-secretase inhibitor.。

理化性质与常数
密度 1.361
GHS 危险性与安全概述
海关编码 29163990
深度关联的国家与行业检测标准 共收录 0 项推荐/强制检测规范 (支持 HPLC/GC/MS 检测方法与基质穿透)
共收录 0 项标准
暂未录入该化合物的直接检测标准,系统已将该CAS号加入自动监控队列。